Immune response against dying tumor cells

Advances in Immunology

Volumn 84, Issue , 2004, Pages 131-179

  Zitvogel, Laurence ^a   Casares, Noelia ^a   Péquignot, Marie O ^a   Chaput, Nathalie ^a   Albert, Matthew L ^b   Kroemer, Guido ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; ARSENIC; CASPASE; CHLOROQUINE; COLECALCIFEROL; CYTOCHROME C; DNA FRAGMENT; DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ETOPOSIDE; FAS LIGAND; FLAVOPIRIDOL; GAMMA INTERFERON; GANCICLOVIR; GELDANAMYCIN; GEMCITABINE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HYDROXYCHLOROQUINE; IMATINIB; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATRIX METALLOPROTEINASE; NORFLOXACIN; PROTEIN TYROSINE KINASE INHIBITOR; RAS PROTEIN; RITUXIMAB; SEOCALCITOL; TRASTUZUMAB; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTIFICIAL EMBOLISM; BREAST CANCER; CAUTERIZATION; CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINE; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CHROMATIN CONDENSATION; CLINICAL TRIAL; COLON CANCER; CRYOSURGERY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISASTER; ELECTROCOAGULATION; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; LIVER CELL CARCINOMA; LYMPH NODE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MICROWAVE RADIATION; MITOSIS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; ONCOGENE RAS; PHAGOCYTE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNITY;

EID: 3042774310     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(04)84004-5     Document Type: Article

References (246)

1. Adams J.M. Ways of dying: Multiple pathways to apoptosis. Genes Dev. 17:2003;2481-2495
2. Akiyama K., Ebihara S., Yada A., Matsumura K., Aiba S., Nukiwa T., Takai T. Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells. J. Immunol. 170:2003;1641-1648
3. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 4:1998a;1321-1324
4. Albert M.L., Jegathesan M., Darnell R.B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2:2001;1010-1017
5. Albert M.L., Kim J.I., Birge R.B. Alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells. Nat. Cell Biol. 2:2000;899-905
6. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1998b;1359-1368
7. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998c;86-89
8. Alonso M., Tamasdan C., Miller D.C., Newcomb E.W. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Mol. Cancer Ther. 2:2003;139-150
9. Amigorena S. Fc gamma receptors and cross-presentation in dendritic cells. J. Exp. Med. 195:2002;F1-3
10. André F., Schartz N.E., Movassagh M., Flament C., Pautier P., Morice P., Pomel C., Lhomme C., Escudier B., Le Chevalier T., Tursz T., Amigorena S., Raposo G., Angevin E., Zitvogel L. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 360:2002;295-305
11. Appel S., Boehmler A.M., Grunebach F., Muller M.R., Rupf A., Weck M.M., Hartmann U., Reichardt V.L., Kanz L., Brummendorf T.H., Brossart P. Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells. Blood. 103:2003;538-544
12. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., Stevenson M.A., Calderwood S.K. Novel signal transduction pathway utilized by extracellular HSP70: Role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277:2002;15028-15034
13. Banchereau J., Palucka A.K., Dhodapkar M., Burkeholder S., Taquet N., Rolland A., Taquet S., Coquery S., Wittkowski K.M., Bhardwaj N., Pineiro L., Steinman R., Fay J. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 61:2001;6451-6458
14. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252
15. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: All roads lead to death. Nat. Rev. Immunol. 2:2002;401-409
16. Basu S., Binder R.J., Ramalingam T., Srivastava P.K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. 14:2001;303-313
17. Basu S., Binder R.J., Suto R., Anderson K.M., Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12:2000;1539-1546
18. Bateman A.R., Harrington K.J., Kottke T., Ahmed A., Melcher A.A., Gough L.J., Linardakis E., Riddle D., Dietz A., Lohse C.M., Strome S., Peterson T., Simari R., Vile R.G. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Cancer Res. 62:2002;6566-6578
19. Becker T., Hartl F.U., Wieland F. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158:2002;1277-1285
20. Beere H.M., Green D.R. Stress management - Heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol. 11:2001;6-10
21. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature. 393:1998;478-480
22. Bennett S.R., Carbone F.R., Karamalis F., Miller J.F., Heath W.R. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med. 198:1997;65-70
23. Berard F., Blanco P., Davoust J., Neidhart-Berard E.M., Nouri-Shirazi M., Taquet N., Rimoldi D., Cerottini J.C., Banchereau J., Palucka A.K. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. 192:2000;1535-1544
24. Beyaert R., Van Loo G., Heyninck K., Vandenabeele P. Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int. Rev. Cytol. 214:2002;225-272
25. Bickerstaff M.C., Botto M., Hutchinson W.L., Herbert J., Tennent G.A., Bybee A., Mitchell D.A., Cook H.T., Butler P.J., Walport M.J., Pepys M.B. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5:1999;852-853
26. Bleday R., Lee E., Jessurun J., Heine J., Wong W.D. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis. Colon Rectum. 36:1993;908-912
27. Bonnotte B., Favre N., Moutet M., Fromentin A., Solary E., Martin M., Martin F. Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors. J. Immunol. 161:1998;1433-1439
28. Bonnotte B., Favre N., Moutet M., Fromentin A., Solary E., Martin M., Martin F. Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes. J. Immunol. 164:2000;1995-2000
29. Borg C., Abdelai J., Laderach D., Mareyama K., Wakasugi H., Charrier S., Ryffel B., Vainchenker W., Galy A., Caignard A., Zitvogel L. Dendritic cell cytoskeleton remodeling promotes synapse formation and IL-12 polarization required for NK cell activation. Blood. 2004;. (in press).
30. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.-L., Metivier D., Ojcius D.M., Jaattela M., Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 197:2003a;1323-1334
31. Boya P., Gonzalez-Polo R.-A., Poncet D., Andreau K., Roumier T., Perfettini J.-L., Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene. 22:2003b;3927-3936
32. Brankin B., Skaar T.C., Brotzman M., Trock B., Clarke R. Autoantibodies to the nuclear phosphoprotein nucleophosmin in breast cancer patients. Cancer Epidemiol. Biomarkers Prev. 7:1998;1109-1115
33. Brown S., Heinisch I., Ross E., Shaw K., Buckley C.D., Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 418:2002;200-203
34. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8:2001;569-581
35. Buttiglieri S., Galetto A., Forno S., De Andrea M., Matera L. Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells. Int. J. Cancer. 106:2003;516-520
36. Castedo M., Ferri K.F., Blanco J., Roumier T., Larochette N., Barretina J., Amendola A., Nardacci R., Metivier D., Este J.A., Piacentini M., Kroemer G. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycinFKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J. Exp. Med. 194:2001;1097-1110
37. Castedo M., Hirsch T., Susin S.A., Zamzami N., Marchetti P., Macho A., Kroemer G. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol. 157:1996;512-521
38. Castedo M., Macho A., Zamzami N., Hirsch T., Marchetti P., Uriel J., Kroemer G. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25:1995;3277-3284
39. Castedo M., Perfettini J.-L., Medema J.P., Kroemer G. Cell death by mitotic catastrophe: A molecular definition. Oncogene. 23:2004a;2825-2837
40. Castedo M., Perfettini J.-L., Roumier T., Valent A., Raslova H., Yakushijin K., Horne D.A., Feunteun J., Lenoir G., Vainchenker W., Kroemer G. Mitotic catastrophe. A special case of apoptosis preventing aneuploidy. Oncogene. 2004b;. (in press).
41. Castedo M., Perfettini J.-L., Roumier T., Yakushijin K., Horne D.A., Medema R., Kroemer G. Chk2 is a negative regulator of mitotic catastrophe. Oncogene. 2004c;. (in press).
42. Castellino F., Boucher P.E., Eichelberg K., Mayhew M., Rothman J.E., Houghton A.N., Germain R.N. Receptor-mediated uptake of antigenheat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191:2000;1957-1964
43. Castiglioni P., Martin-Fontecha A., Milan G., Tomajer V., Magni F., Michaelsson J., Rugarli C., Rosato A., Bellone M. Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells. Cancer Res. 62:2002;1116-1122
44. Chakrabarti A., Chakrabarti S. High yield of micronuclei and micronuclei premature chromosome condensation in a mouse tumor cell line cultured in vivo with prearrested mitotic metaphases. Neoplasma. 34:1987;557-562
45. Chan H.T., Hughes D., French R.R., Tutt A.L., Walshe C.A., Teeling J.L., Glennie M.J., Cragg M.S. CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts. Cancer Res. 63:2003;5480-5489
46. Chattergoon M.A., Kim J.J., Yang J.S., Robinson T.M., Lee D.J., Dentchev T., Wilson D.M., Ayyavoo V., Weiner D.B. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat. Biotechnol. 18:2000;974-979
47. Chen W., Frank M.E., Jin W., Wahl S.M. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity. 14:2001;715-725
48. Cheng E.H.-Y.A., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711
49. Chinnaiyan A.M., Dixit V.M. The cell-death machine. Curr. Biol. 6:1996;555-562
50. Clynes R.A., Towers T.L., Presta L.G., Ravetch J.V. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat. Med. 6:2000;443-446
51. Coulie P.G., Karanikas V., Colau D., Lurquin C., Landry C., Marchand M., Dorval T., Brichard V., Boon T. A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc. Natl. Acad. Sci. USA. 98:2001;10290-10295
52. Coumans B., Thellin O., Zorzi W., Melot F., Bougoussa M., Melen L., Zorzi D., Hennen G., Igout A., Heinen E. Lymphoid cell apoptosis induced by trophoblastic cells: A model of active feto-placental tolerance. J. Immunol. Methods. 224:1999;185-196
53. Debatin K.M., Poncet D., Kroemer G. Chemotherapy: Targeting the mitochondrial pathway. Oncogene. 21:2002;8786-8803
54. Denecker G., Declercq W., Geuijen C.A., Boland A., Benabdillah R., van Gurp M., Sory G., Zhivotovsky B., Fiers W., Grooten J., Declecq W., Vandenabeele P. Death receptor-induced apoptotic and necrotic cell death: Differential role of caspases and mitochondria. Cell Death Differ. 8:2001;829-840
55. Denzer K., Kleijmeer L.J., Heijnen H.F., Stoorvogel W., Geuze H.J. Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113:2000a;3365-3374
56. Denzer K., van Eijk M., Kleijmeer M.J., Jakobson E., de Groot C., Geuze H.J. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J. Immunol. 165:2000b;1259-1265
57. Dreno B., Nguyen J.M., Khammari A., Pandolfino M., Tessier M.H., Bercegeay S., Cassidanius A., Lemarre P., Billaudel S., Labarriere N., Jotereau F. Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Cancer Immunol. Immunother. 2002:2002;539-546
58. Dudley M.E., Rosenberg S.A. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer. 3:2003;666-675
59. Fadok V.A., Bratton D.L., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrineparacrine mechanisms involving TGF-B, PGE2, and PAF. J. Clin. Invest. 101:1998;890-898
60. Feng H., Zeng Y., Graner M.W., Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood. 100:2002;4108-4115
61. Feng H., Zeng Y., Graner M.W., Likhacheva A., Katsanis E. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood. 101:2003;245-252
62. Feng H., Zeng Y., Whitesell L., Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood. 97:2001;3505-3512
63. Ferguson T.A., Herndon J., Elzey B., Griffith T.S., Schoenberger S., Green D.R. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness. J. Immunol. 168:2002;5589-5595
64. Ferri K.F., Jacotot E., Blanco J., Esté J.A., Zamzami A., Susin S.A., Brothers G., Reed J.C., Penninger J.M., Kroemer G. Apoptosis control in syncytia induced by the HIV-1-envelope glycoprotein complex. Role of mitochondria and caspases. J. Exp. Med. 192:2000;1081-1092
65. Ferri K.F., Kroemer G. Control of apoptotic DNA degradation. Nat. Cell Biol. 2:2001a;E63-E64
66. Ferri K.F., Kroemer G.K. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3:2001b;E255-E263
67. Flohe S.B., Bruggemann J., Lendemans S., Nikulina M., Meierhoff G., Flohe S., Kolb H. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 170:2003;2340-2348
68. Fonteneau J.F., Kavanagh D.G., Lirvall M., Sanders C., Cover T.L., Bhardwaj N., Larsson M. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood. 102:2003;4448-4455
69. Formigl L., Papucci L., Tani A., Schiavone N., Tempestini A., Orlandini G.E., Capaccioli S., Orlandini S.Z. Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J. Cell Physiol. 182:2000;41-49
70. Fulda S., Debatin K.M. Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med. Pediatr. Oncol. 35:2000;616-618
71. Galetto A., Buttiglieri S., Forno S., Moro F., Mussa A., Matera L. Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells. Anticancer Drugs. 14:2003;833-843
72. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5:1999;1249-1255
73. Garrido C., Gurbuxani S., Ravagnan L., Kroemer G. Heat shock proteins: Endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Comm. 286:2001;433-442
74. Garrido C., Schmitt E., Cande C., Vahsen N., Parcellier A., Kroemer G. HSP27 and HSP70: Potentially oncogenic apoptosis inhibitors. Cell Cycle. 2:2003;579-584
75. Gehrmann M., Pfister K., Hutzler P., Gastpar R., Margulis B., Multhoff G. Effects of antineoplastic agents on cytoplasmic and membrane-bound heat shock protein 70 (Hsp70) levels. Biol. Chem. 383:2002;1715-1725
76. Gottfried E., Krieg R., Eichelberg C., Andreesen R., Mackensen A., Krause S.W. Characterization of cells prepared by dendritic cell-tumor cell fusion. Cancer Immun. 2:2002;15
77. Grammer A.C., Lipsky P.E. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv. Immunol. 76:2000;61-178
78. Green D.R., Evan G.I. A matter of life and death. Cancer Cell. 1:2002;19-30
79. Green D.R., Kroemer G. The central executioner of apoptosis: Mitochondria or caspases? Trends Cell Biol. 8:1998;267-271
80. Gregoire M., Ligeza-Poisson C., Juge-Morineau N., Spisek R. Anti-cancer therapy using dendritic cells and apoptotic tumour cells: Pre-clinical data in human mesothelioma and acute myeloid leukaemia. Vaccine. 21:2003;791-794
81. Gross C., Hansch D., Gastpar R., Multhoff G. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol. Chem. 384:2003a;267-279
82. Gross C., Koelch W., DeMaio A., Arispe N., Multhoff G. Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. J. Biol. Chem. 278:2003b;41173-41181
83. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature. 25:2003;397-402
84. Gurbuxani S., Bruey J.M., Fromentin A., Larmonier N., Parcellier A., Jaattela M., Martin F., Solary E., Garrido C. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene. 20:2001;7478-7485
85. Gurbuxani S., Schmitt E., Cande C., Parcellier A., Hamman A., Daugas E., Kouranti I., Spahr C., Pance A., Kroemer G., Garrido C. Heat shock protein 70-binding inhibits the nuclear import of apoptosis inducing factor. Oncogene. 22:2003;6669-6678
86. Hansen M.H., Nielsen H., Ditzel H.J. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. Proc. Natl. Acad. Sci. USA. 98:2001;12659-12664
87. Hayashi T., Hideshima T., Akiyama M., Raje N., Richardson P., Chauhan D., Anderson K.C. Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes. Blood. 102:2003;1435-1442
88. Hayward R.L., Macpherson J.S., Cummings J., Monia B.P., Smyth J.F., Jodrell D.J. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. Clin. Cancer Res. 9:2003;2856-2865
89. Heald R., McLoughlin M., McKeon F. Human weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell. 74:1993;463-474
90. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:2001;47-64
91. Henry F., Boisteau O., Bretaudeau L., Lieubeau B., Meflah K., Gregoire M. Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res. 59:1999;3329-3332
92. Herr I., Debatin K.M. Cellular stress response and apoptosis in cancer therapy. Blood. 98:2001;2603-2614
93. Hirsch T., Marchetti P., Susin S.A., Dallaporta B., Zamzami N., Marzo I., Geuskens M., Kroemer G. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene. 15:1997;1573-1582
94. Houde M., Bertholet S., Gagnon E., Brunet S., Goyette G., Laplante A., Princiotta M.F., Thibault P., Sacks D., Desjardins M. Phagosomes are competent organelles for antigen cross-presentation. Nature. 425:2003;351-352
95. Huang A.V., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:1994;961-965
96. Hugues S., Mougneau E., Ferlin W., Jeske D., Hofman P., Homann D., Beaudoin L., Schrike C., Von Herrath M., Lehuen A., Glaichenhaus N. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity. 16:2002;169-181
97. Huynh M.L., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109:2002;41-50
98. Ignatius R., Marovich M., Mehlhop E., Villamide L., Mahnke K., Cox W.I., Isdell F., Frankel S.S., Mascola J.R., Steinman R.M., Pope M. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion. J. Virol. 74:2000;11329-11338
99. Imai H., Ochs R.L., Kiyosawa K., Furuta S., Nakamura R.M., Tan E.M., Keck W.M. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am. J. Pathol. 140:1992;859-870
100. Inbal B., Bialik S., Sabanay I., Shani G., Kimchi A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J. Cell Biol. 157:2002;455-468
101. Jaattela M., Tschopp J. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4:2003;416-423
102. Jaeschke H., Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemiareperfusion injury. Gastroenterology. 125:2003;246-257
103. Jamison J.M., Gilloteaux J., Taper H.S., Calderon P.B., Summers J.L. Autoschizis: A novel cell death. Biochem. Pharmacol. 63:2002;1773-1783
104. Jeha S. Tumor lysis syndrome. Semin Hematol. 38:2001;4-8S
105. Johnstone R.M., Adam M., Hammond J.R., Orr L., Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262:1987;9412-9420
106. Joza N., Kroemer G., Penninger J.M. Genetic analysis of the mammalian cell death machinery. Trends Genet. 18:2002;142-149
107. Kanzawa T., Kondo Y., Ito H., Kondo S., Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 63:2003;2103-2108
108. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA. 95:1998;7556-7561
109. Karlsson M., Lundin S., Dahlgren U., Kahu H., Pettersson I., Telemo E. "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 31:2001;2892-2900
110. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257
111. Khong H.T., Restifo N.P. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat. Immunol. 3:2002;999-1005
112. Kitanaka C., Kato K., Ijiri R., Sakurada K., Tomiyama A., Noguchi K., Nagashima Y., Nakagawara A., Momoi T., Toyoda Y., Kigasawa H., Nishi T., Shirouzu M., Yokoyama S., Tanaka Y., Kuchino Y. Increased Ras expression and caspase-independent neuroblastoma cell death: Possible mechanism of spontaneous neuroblastoma regression. J. Natl. Cancer. Inst. 94:2002;358-368
113. Kokhaei P., Rezvany M.R., Virving L., Choudhury A., Rabbani H., Osterborg A., Mellstedt H. Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumor hybrids in B-CLL. Leukemia. 17:2003;894-899
114. Kotera Y., Shimizu K., Mule J.J. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res. 61:2001;8105-8109
115. Krammer P.H. CD95's deadly mission in the immune system. Nature. 407:2000;789-795
116. Kroemer G. The pharmacology of T cell apoptosis. Adv. Immunol. 58:1995;211-296
117. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620
118. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial deathlife regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:1998;619-642
119. Kroemer G., Petit P.K., Zamzami N., Vayssière J.-L., Mignotte B. The biochemistry of apoptosis. FASEB J. 9:1995;1277-1287
120. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519
121. Kubasiak L.A., Hernandez O.M., Bishopric N.H., Webster K.A. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. USA. 99:2002;12825-12830
122. Kurosaka K., Takahashi M., Watanabe N., Kobayashi Y. Silent cleanup of very early apoptotic cells by macrophages. J. Immunol. 171:2003;4672-4679
123. Kurts C. Cross-presentation: Inducing CD8 T cell immunity and tolerance. J. Mol. Med. 78:2000;326-332
124. Kurts C., Carbone F.R., Barnden M., Blanas E., Allison J., Heath W.R., Miller J.F. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186:1997a;2057-2062
125. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:1996;923-930
126. Kurts C., Kosaka H., Carbone F.R., Miller J.F., Heath W.R. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 186:1996;239-245
127. Lamy L., Ticchioni M., Rouquette-Jazdanian A.K., Samson M., Deckert M., Greenberg A.H., Bernard A. CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis. J. Biol. Chem. 278:2003;23915-23921
128. Larmonier N., Billerey C., Rebe C., Parcellier A., Moutet M., Fromentini A., Kroemer G., Garrido C., Solary E., Martin F., Bonnotte B. An atypical caspase-independent death pathway for an immunogenic cancer cell line. Oncogene. 21:2002;6091-6100
129. Leist M., Jaattela M. Four deaths and a funeral: From caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2:2001;589-598
130. Leist M., Single B., Castoldi A.F., Kühnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1997;1481-1486
131. Li M., Carpio D.F., Zheng Y., Bruzzo P., Singh V., Ouaaz F., Medzhitov R.M., Beg A.A. An essential role of the NF-kappa BToll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166:2001;7128-7135
132. Liu K., Iyoda T., Saternus M., Kimura Y., Inaba K., Steinman R.M. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:2002;1091-1097
133. Liu X.S., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome. c. Cell. 86:1996;147-157
134. Lockshin R.A., Zakeri Z. Caspase-independent cell deaths. Curr. Opin. Cell Biol. 14:2002;727-733
135. Lucas M., Stuart L.M., Savill J., Lacy-Hulbert A. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J. Immunol. 171:2003;2610-2615
136. Machy P., Serre K., Leserman L. Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur. J. Immunol. 30:2000;848-857
137. Mackensen A., Herbst B., Chen J.L., Kohler G., Noppen C., Herr W., Spagnoli G.C., Cerundolo V., Lindemann A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int. J. Cancer. 86:2000;385-392
138. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146:1995;3-15
139. Martin S.J., Green D.R. Protease activation during apoptosis: Death by a thousand cuts? Cell. 82:1995;349-352
140. Martinon F., Burns K., Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell. 10:2002;417-426
141. Masse D., Voisine C., Henry F., Cordel S., Barbieux I., Josien R., Meflah K., Gregoire M., Lieubeau B. Increased vaccination efficiency with apoptotic cells by silica-induced, dendritic-like cells. Cancer Res. 62:2002;1050-1056
142. Mathiasen I.S., Sergeev I.N., Bastholm L., Elling F., Norman A.W., Jaattela M. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J. Biol. Chem. 277:2002;30738-30745
143. Matzinger P. The danger model: A renewed sense of self. Science. 296:2002;301-305
144. Melcher A., Todryk S., Hardwick N., Ford M., Jacobson M., Vile R.G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4:1998;581-587
145. Mellman I., Steinman R.M. Dendritic cells: Specialized and regulated antigen processing machines. Cell. 106:2001;255-258
146. Mihm M.H.J., Clemente C.G., Cascinelli N. Tumor infiltrating lymphocytes in lymph node melanoma metastases: A histopathologic prognostic indicator and an expression of local immune response. Lab. Invest. 74:1996;43-47
147. Moroi V., Mayhew M., Trcka J., Hoe M.H., Takechi Y., Hartl F.U., Rothman J.E., Houghton A.N. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proc. Natl. Acad. Sci. USA. 97:2000;3485-3490
148. Nagy Z.A., Mooney N.A. A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules. J. Mol. Med. 81:2003;157-165
149. Nakano O., Sato M., Naito Y., Suzuki K., Orikasa S., Aizawa M., Suzuki Y., Shintaku I., Nagura H., Ohtani H. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: Clinicopathologic demonstration of antitumor immunity. Cancer Res. 61:2001;5132-5136
150. Nalesnik M.A. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res. 159:2002;9-18
151. Nicholson D.W., Thornberry N.A. Caspases: Killer proteases. Trends Biochem. Sci. 22:1997;299-306
152. Noessner E., Gastpar R., Milani V., Brandl A., Hutzler P.J., Kuppner M.C., Roos M., Kremmer E., Asea A., Calderwood S.K., Issels R.D. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J. Immunol. 169:2002;5424-5432
153. Nowak A.K., Lake R.A., Marzo A.L., Scott B., Heath W.R., Collins E.J., Frelinger J.A., Robinson B.W. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J. Immunol. 170:2003a;4905-4913
154. Nowak A.K., Robinson B.W., Lake R.A. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res. 63:2003b;4490-4496
155. Nylandsted J., Wick W., Hirt U.A., Brand K., Rohde M., Leist M., Weller M., Jaattela M. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res. 62:2002;7139-7142
156. Ochsenbein A.F., Sierro S., Odermatt B., Pericin M., Karrer U., Hermans J., Hemmi S., Hengartner H., Zinkernagel R.M. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature. 411:2001;1058-1064
157. Ogier-Denis E., Codogno P. Autophagy: A barrier or an adaptive response to cancer. Biochim. Biophys. Acta. 1603:2003;113-128
158. Okada M., Adachi S., Imai T., Watanabe K., Toyokuni S., Ueno M., Zervos A.S., Kroemer G., Nakahata T. A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL positive human leukemic cells - Caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood. 2004;. (in press).
159. Pardoll D.M. Spinning molecular immunology into successful immunotherapy. Nat. Rev. Immunol. 2:2002;227-238
160. Peiser L., Mukhopadhyay S., Gordon S. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14:2002;123-128
161. Penn I. Post-transplant malignancy: The role of immunosuppression. Drug Saf. 23:2000;101-113
162. Penninger J.M., Kroemer G. Molecular and cellular mechanisms of T lymphocyte apoptosis. Adv. Immunol. 68:1998;51-144
163. Penninger J.M., Kroemer G. Caspases, AIF, and mitochondria: Rivaling for cell death execution. Nat. Cell Biol. 5:2003;97-99
164. Perfettini J.-L., Kroemer G. Caspase activation is not death. Nat. Immunol. 4:2003;308-310
165. Pettersen R.D., Bernard G., Olafsen M.K., Pourtein M., Lie S.O. CD99 signals caspase-independent T cell death. J. Immunol. 166:2001;4931-4942
166. Phan G.Q., Yang J.C., Sherry R.M., Hwu P., Topalian S.L., Schwartzentruber D.J., Restifo N.P., Haworth L.R., Seipp C.A., Freezer L.J., Morton K.E., Mavroukakis S.A., Duray P.H., Steinberg S.M., Allison J.P., Davis T.A., Rosenberg S.A. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA. 100:2003a;8372-8377
167. Phan V., Errington F., Cheong S.C., Kottke T., Gough M., Altmann S., Brandenburger A., Emery S., Strome S., Bateman A., Bonnotte B., Melcher A., Vile R. A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Nat. Med. 9:2003b;1215-1219
168. Quaranta M.G., Mattioli B., Spadaro F., Straface E., Giordani L., Ramoni C., Malorni W., Viora M. HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 17:2003;2025-2036
169. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., Geuze H.J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1996;1161-1172
170. Rashmi R., Kumar S., Karunagaran D. Ectopic expression of hsp70 confers resistance, and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis. 25:2004;179-187
171. Ravagnan L., Gurbuxani S., Susin S.A., Maisse C., Daugas E., Zamzami N., Mak T., Jaattela M., Penninger J.M., Garrido C., Kroemer G. Heat shock protein 70 antagonizes apoptosis inducing factor. Nat. Cell Biol. 3:2001;839-843
172. Read S.H., Baliga B.C., Ekert P.G., Vaux D.L., Kumar S. A novel Apaf-1-independent putative caspase-2 activation complex. J. Cell Biol. 159:2002;739-745
173. Rebbaa A., Zheng X., Chou P.M., Mirkin B.L. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene. 22:2003;2805-2811
174. Reiter I., Krammer B., Schwamberger G. Cutting edge: Differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J. Immunol. 163:1999;1730-1732
175. Restifo N.P., Marincola F.M., Kawakami Y., Taubenberger J., Yannelli J.R., Rosenberg S.A. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst. 88:1996;100-108
176. Ribas A., Butterfield L.H., Glaspy J.A., Economou J.S. Current developments in cancer vaccines and cellular immunotherapy. J. Clin. Oncol. 21:2003;2415-2432
177. Rodenburg R.J., Raats J.M., Pruijn G.J., van Venrooij W.J. Cell death: A trigger of autoimmunity? Bioessays. 22:2000;627-636
178. Ronchetti A., Rovere P., Iezzi G., Galati G., Heltai S., Protti M.P., Garancini M.P., Manfredi A.A., Rugarli C., Bellone M. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines. J. Immunol. 163:1999;130-136
179. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res. 63:2003;2705-2715
180. Roninson I.B., Broude E.V., Chang B.-D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resistance Updates. 4:2001;303-313
181. Rosen A., Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6:1999;6-12
182. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature. 411:2001;380-384
183. Rovere P., Manfredi A.A., Vallinoto C., Zimmermann V.S., Fascio U., Balestrieri G., Ricciardi-Castagnoli P., Rugarli C., Tincani A., Sabbadini M.G. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. J. Autoimmun. 11:1998a;403-411
184. Rovere P., Vallinoto C., Bondanza A., Crosti M.C., Rescigno M., Ricciardi-Castagnoli P., Rugarli C., Manfredi A.A. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161:1998b;4467-4471
185. Sasaki S., Amara R.R., Oran A.E., Smith J.M., Robinson H.L. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspase. Nat. Biotechnol. 19:2001;543-547
186. Sausville E.A., Tomaszewski J.E., Ivy P. Clinical development of 17-allylamino, 17-demethoxygeldanamycin. Curr. Cancer Drug Targets. 3:2003;377-383
187. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:2000;423-434
188. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784
189. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.-M., Krammer P.H., Peter M.E. Two CD95 (APO-1Fas) signaling pathways. EMBO J. 17:1998;1675-1687
190. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:2002;191-195
191. Scheffer S.R., Nave H., Korangy F., Schlote K., Pabst R., Jaffee E.M., Manns M.P., Greten T.F. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int. J. Cancer. 103:2003;205-211
192. Schmitt C.A. Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nat. Rev. Cancer. 3:2003;286-295
193. Schmitt C.A., Fridman J.S., Yang M., Baranov E., Hoffman R.M., Lowe S.W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell. 1:2002a;289-298
194. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 109:2002b;335-346
195. Schmitt E., Gurbuxani S., Cande C., Parcellier A., Hamman A., Morales M.C., Kroemer G., Giordanetto F., Jaattela M., Pance A., Penninger J.M., Kroemer G., Garrido C. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis inducing factor mutant. Cancer Res. 63:2003;8233-8240
196. Schmitt E., Parcellier A., Ghiringhelli F., Casares N., Gurbuxani S., Droin N., Hamai A., Pequignot M., Hamman A., Moutet M., Fromentin A., Kroemer G., Solary E., Garrido C. Increased immunogenicity of colon cancer cells by selective depletion of cytochrome. c. Cancer Res. 64:2004;2705-2711
197. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 411:2001;207-211
198. Selenko N., Maidic O., Draxier S., Berer A., Jager U., Knapp W., Stockl J. CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells. Leukemia. 15:2001;1619-1626
199. Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., Schreiber R.D. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;1107-1111
200. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 425:2003;516-521
201. Shi Y., Zheng W., Rock K.L. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA. 97:2000;14590-14595
202. Singh-Jasuja H., Toes R.E., Spee P., Munz C., Hilf N., Schoenberger S.P., Ricciardi-Castagnoli P., Neefjes J., Rammensee H.G., Arnold-Schild D., Schild H. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 191:2000;1965-1974
203. Skokos D., Botros H.G., Demeure C., Morin J., Peronet R., Birkenmeier G., Boudaly S., Mecheri S. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J. Immunol. 170:2003;3037-3045
204. Smith M.R. Rituximab (monoclonal anti-CD20 antibody): Mechanisms of action and resistance. Oncogene. 22:2003;7359-7368
205. Smyth M.J., Thia K.V., Street S.E., MacGregor D., Godfrey D.I., Trapani J.A. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 192:2000;755-760
206. Snyder E.L., Kuter D.J. Apoptosis in transfusion medicine: Of death and dying - is that all there is? Transfusion. 40:2000;135-138
207. Sozzani S., Allavena P., D'Amico G., Luini W., Bianchi G., Kataura M., Imai T., Yoshie O., Bonecchi R., Mantovani A. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties. J. Immunol. 161:1998;1083-1086
208. Sperandio S., de Belle I., Bredesen D.E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA. 97:2000;14376-14381
209. Sperling K., Ra P.N. Mammalian cell fusion. V. Replication behaviour of heterochromatin as observed by premature chromosome condensation. Chromosoma. 14:1974;121-131
210. Srivastava P.K., Udono H., Blachere N.E., Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 39:1994;93-98
211. Steinman R.M., Turley S., Mellman I., Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:2000;411-416
212. Street S.E., Trapani J.A., MacGregor D., Smyth M.J. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J. Exp. Med. 196:2002;129-134
213. Strome S.E., Voss S., Wilcox R., Wakefield T.L., Tamada K., Flies D., Chapoval A., Lu J., Kasperbauer J.L., Padley D., Vile R., Gastineau D., Wettstein P., Chen L. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 62:2002;1884-1889
214. Surh C.D., Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 372:1994;100-103
215. Susin S.A., Daugas E., Ravagnan L., Samejima K., Zamzami N., Loeffler M., Costantini P., Ferri K.F., Irinopoulou T., Prévost M.-C., Brothers G., Mak T.W., Penninger J., Earnshaw W.C., Kroemer G. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192:2000;571-579
216. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446
217. Taieb J., Maruyama K., Terme M., Borg C., Zitvogel L. Imatinib mesylate inhibits Flt-3 ligand-mediated tumor eradication in vivo. Blood. 103:2004;538-544
218. Takeda K., Smyth M.J., Cretney E., Hayakawa Y., Kayagaki N., Yagita H., Okumura K. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195:2002;161-169
219. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192:2000;359-366
220. te Poele R.H., Okorokov A.L., Jardine L., Cummings J., Joel S.P. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 62:2002;1876-1883
221. Thery C., Boussac M., Veron P., Ricciardi-Castagnoli P., Raposo G., Garin J., Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166:2001;7309-7318
222. Thery C., Duban L., Segura E., Veron P., Lantz O., Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3:2002a;1156-1162
223. Thery C., Regnault A., Garin J., Wolfers J., Zitvogel L., Ricciardi-Castagnoli P., Raposo G., Amigorena S. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell. Biol. 147:1999;599-610
224. Thery C., Zitvogel L., Amigorena S. Exosomes: Composition, biogenesis and function. Nat. Rev. Immunol. 2:2002b;569-579
225. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462
226. Trofe J., Buell J.F., First M.R., Hanaway M.J., Beebe T.M., Woodle E.S. The role of immunosuppression in lymphoma. Recent Results Cancer Res. 159:2002;55-66
227. Tschopp J., Martinon F., Burns K. NALPs: A novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4:2003;95-104
228. Turley S.J., Inaba K., Garrett W.S., Ebersold M., Unternaehrer J., Steinman R.M., Mellman I. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288:2000;522-527
229. Ulanet D.B., Torbenson M., Dang C.V., Casciola-Rosen L., Rosen A. Unique conformation of cancer autoantigen B23 in hepatoma: A mechanism for specificity in the autoimmune response. Proc. Natl. Acad. Sci. USA. 100:2003;12361-12366
230. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., Wagner H. HSP70 as endogenous stimulus of the tollinterleukin-1 receptor signal pathway. J. Biol. Chem. 277:2002;15107-15112
231. van Der Merwe P.A., Davis S.J. Immunology. The immunological synapse - a multitasking system. Science. 295:2002;1479-1480
232. Vanden Berghe T., Kalai M., Van Loo G., Declercq W., Vandenabeele P. Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis. J. Biol. Chem. 278:2003;5622-5629
233. Vandivier R.W., Fadok V.A., Hoffmann P.R., Bratton D.L., Penvari C., Brown K.K., Brain J.D., Accurso F.J., Henson P.M. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J. Clin. Invest. 109:2002;661-670
234. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben-Tal O., Kutikov I., Gill O., Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196:2002;1553-1561
235. Vercammen D., Brouckaert G., Denecker G., VandeCraen M., Declercq W., Fiers W., Vandenabeele P. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188:1998;919-930
236. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15:2002;2922-2933
237. Wolfers J., Lozier A., Raposo G., Regnault A., Thery C., Masurier C., Flament C., Pouzieux S., Faure F., Tursz T., Angevin E., Amigorena S., Zitvogel L. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7:2001;297-303
238. Wu J.J., Orengo I.F. Squamous cell carcinoma in solid-organ transplantation. Dermatol. Online J. 8:2002;4
239. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., Slot J.W., Geuze H.J., Stoorvogel W. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem. 278:2003;10963-10972
240. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., Felix R., Schlag P.M. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3:2002;487-497
241. Xue L., Fletcher G.C., Tolkovsky A.M. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr. Biol. 6:2001;361-365
242. Yee C., Thompson J.A., Roche P., Byrd D.R., Lee P.P., Piepkorn M., Kenyon K., Davis M.M., Riddell S.R., Greenberg P.D. Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo. J. Exp. Med. 192:2000;1637-1644
243. Yrlid U., Wick M.J. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191:2000;613-624
244. Zamzami N., Kroemer G. Mitochondrial membrane permeabilization in apoptosis. The (w)hole story? Curr. Biol. 13:2003;R71-R73
245. Zhang L., Conejo-Garcia J.R., Katsaros D., Gimotty P.A., Massobrio M., Regnani G., Makrigiannakis A.H.G., Schlienger K., Liebman M.N., Rubin S.C., Coukos G. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348:2003;203-213
246. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat. Med. 4:1998;594-600